GlobalRPh Renal Dosing Masterv6.6
Evidence addition

Bupropion extended-release (WELLBUTRIN XL)

Local RX List renal extractBase record retrieved 2026-09-07See the evidence for this drug2 sources available - open source summaries, references and comparisons

Wellbutrin XL

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (2)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

1 additional source qualifications - review before use
Renal cautions are not interchangeable release-form schedules

SR and XL renal excerpts both recommend considering a lower dose and/or frequency, but do not provide a complete numeric renal schedule. Their release forms and ordinary administration schedules remain separate.

Before applying: Open the correct release-form record. Do not invent a shared renal interval or transfer a single-dose limit from another formulation.

Also check: Renal cautions are not interchangeable release-form schedules

Rxlist source

GlobalRPh RX List - Wellbutrin XL

Product / population
Adult product-specific renal information; not a complete prescribing regimen.
Renal measure
GFR, mL/min, as printed; no equation/indexing specified.

RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.

Renal dosing, restrictions and evidence limits

For GFR below 90 mL/min, consider reducing the XL dose and/or administration frequency. Renally cleared metabolites can accumulate; monitor for exposure-related adverse effects. No universal renal tablet strength or interval is supplied. The adjacent hepatic dosing instructions are not a renal algorithm, and SR and XL should remain formulation-specific.

Source revision: Source revision date not established in selected retrieval. | Retrieved: 2026-09-07. Retrieval date is not the revision date.

Source: https://globalrph.com/rx-list/wellbutrin-xl-drug/

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

GlobalRPh RX List

GlobalRPh RX List - Wellbutrin XL

Qualitative renal precaution. No complete numerical renal schedule is supplied by this selected finding.

WELLBUTRIN XL, not immediate-release or SR.

Renal method: GFR, mL/min, as printed in dose subsection.
Retrieved: 2026-09-07

Read local renal resultOpen original reference
GlobalRPh RX List

GlobalRPh RX List - Wellbutrin XL

Qualitative renal precaution. No complete numerical renal schedule is supplied by this selected finding.

Adult product-specific renal information; not a complete prescribing regimen.

Renal method: GFR, mL/min, as printed; no equation/indexing specified.
Retrieved: 2026-09-07

Read local renal resultOpen original reference

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources
Jump to renal guidanceRead 1 difference / caution notesClinician guide

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

formulation separation

Renal cautions are not interchangeable release-form schedules

SR and XL renal excerpts both recommend considering a lower dose and/or frequency, but do not provide a complete numeric renal schedule. Their release forms and ordinary administration schedules remain separate.

How to use this: Open the correct release-form record. Do not invent a shared renal interval or transfer a single-dose limit from another formulation.

GlobalRPh RX List - Wellbutrin XLBupropion sustained-release (WELLBUTRIN SR)

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Original content / product scopeGlobalRPh RX List - Wellbutrin XLGlobalRPh RX List - Wellbutrin XL
Choose two source checkboxes below.
Exact product and population matter. This added page contains locally stored, source-specific clinical summaries. Historical handbook information, when present, is identified separately and may conflict with U.S. labeling. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Exact product and population

Product identity selected for the separately displayed source protocols below. Reference: https://globalrph.com/rx-list/wellbutrin-xl-drug/

Product and population scope

WELLBUTRIN XL, not immediate-release or SR.

RDM33-SCOPE-bupropion-wellbutrin-xl-C1 · Source section: Exact product identity and selected populationRenal section finder
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - Wellbutrin XL

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · WELLBUTRIN XL, not immediate-release or SR.

Renal method: GFR, mL/min, as printed in dose subsection.
Source date: Revised March 2024
Retrieved: 2026-09-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Qualitative renal precaution. No complete numerical renal schedule is supplied by this selected finding.

Locally imported selected source sections; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

For renal impairment with GFR below 90 mL/min, consider reducing the dose and/or dosing frequency. The renal subsection does not supply a fixed percentage reduction or interval table. Do not misapply the separate hepatic-impairment schedule as the renal schedule.

RDM33-rxlist-bupropion-wellbutrin-xl-C1 · Source locator: Dose adjustment in patients with renal impairment.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/wellbutrin-xl-drug/
Retrieved
2026-09-07
Renal-function method
GFR, mL/min, as printed in dose subsection.
Source date/version
Revised March 2024
Hash meaning
SHA-256 of the local authored summary only; original HTML/PDF/SPL bytes are not bundled or hashed.
Local summary SHA-256
0359acb1cd3d72ef2b32a7adc84ab077318fdb89615356a7cbef173f3c289b2e
Rxlist

GlobalRPh RX List - Wellbutrin XL

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · Adult product-specific renal information; not a complete prescribing regimen.

Renal method: GFR, mL/min, as printed; no equation/indexing specified.
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Qualitative renal precaution. No complete numerical renal schedule is supplied by this selected finding.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

For GFR below 90 mL/min, consider reducing the XL dose and/or administration frequency. Renally cleared metabolites can accumulate; monitor for exposure-related adverse effects. No universal renal tablet strength or interval is supplied. The adjacent hepatic dosing instructions are not a renal algorithm, and SR and XL should remain formulation-specific.

RDM34-rxlist-wellbutrin-xl-drug-C1 · Source locator: Dose adjustment in renal impairment; use in specific populations: renal impairment.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/wellbutrin-xl-drug/
Retrieved
2026-09-07
Renal-function method
GFR, mL/min, as printed; no equation/indexing specified.
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only, not original HTML, PDF or SPL bytes.
Local summary SHA-256
43948d7e9643bb467dddff5362e5be2c3cfb93d4c796edcbc2397e583c63834a

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 2 RX List, 0 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/rx-list/wellbutrin-xl-drug/
Source retrieval
2026-09-07. This is not the source publication or label revision date.
Original source type
rxlist summary
Local text SHA-256
b835953fb6a34c811869082e94563963bb3e77443977befedd6038d26ce68117
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

This page is an additional exact-product entry, not a recovered GlobalRPh monograph. Its primary scope text and separately attributed clinical summaries are locally included.

Read the full coverage report